Gary Gaglione

2018

In 2018, Gary Gaglione earned a total compensation of $242.6K as Former Chief Financial Officer at Matinas BioPharma Holdings, a 55% decrease compared to previous year.

Compensation breakdown

Option Awards$77,617
Salary$165,000
Total$242,617

Gaglione received $165K in salary, accounting for 68% of the total pay in 2018.

Gaglione also received $77.6K in option awards.

Rankings

In 2018, Gary Gaglione's compensation ranked 13,492nd out of 14,244 executives tracked by ExecPay. In other words, Gaglione earned more than 5.3% of executives.

ClassificationRankingPercentile
All
13,492
out of 14,244
5th
Division
Manufacturing
5,452
out of 5,759
5th
Major group
Chemicals And Allied Products
2,034
out of 2,122
4th
Industry group
Drugs
1,741
out of 1,811
4th
Industry
Pharmaceutical Preparations
1,329
out of 1,385
4th
Source: SEC filing on September 24, 2019.

Gaglione's colleagues

We found four more compensation records of executives who worked with Gary Gaglione at Matinas BioPharma Holdings in 2018.

2018

Jerome Jabbour

Matinas BioPharma Holdings

Chief Executive Officer

2018

Roelof Rongen

Matinas BioPharma Holdings

Chief Executive Officer

2018

Theresa Matkovits

Matinas BioPharma Holdings

Chief Development Officer

2018

Raphael Mannino

Matinas BioPharma Holdings

Chief Scientific Officer

News

You may also like